IRIS - Res&Arch Institutional Research Information System - Research & Archive

LUCIDI, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.050
EU - Europa 1.594
AS - Asia 576
OC - Oceania 13
AF - Africa 8
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.246
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.042
IE - Irlanda 338
UA - Ucraina 304
IT - Italia 254
SG - Singapore 252
SE - Svezia 205
HK - Hong Kong 119
FI - Finlandia 104
CN - Cina 103
DE - Germania 99
FR - Francia 83
RU - Federazione Russa 83
VN - Vietnam 58
GB - Regno Unito 52
TR - Turchia 19
AT - Austria 15
AU - Australia 11
CH - Svizzera 11
BE - Belgio 9
CZ - Repubblica Ceca 9
GR - Grecia 6
LB - Libano 6
PL - Polonia 6
RO - Romania 6
IN - India 5
UZ - Uzbekistan 5
CA - Canada 4
NL - Olanda 4
MX - Messico 3
TW - Taiwan 3
ZA - Sudafrica 3
BR - Brasile 2
BW - Botswana 2
DK - Danimarca 2
EE - Estonia 2
EG - Egitto 2
EU - Europa 2
KR - Corea 2
NZ - Nuova Zelanda 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
ID - Indonesia 1
IL - Israele 1
LV - Lettonia 1
PA - Panama 1
Totale 4.246
Salva come PNG Salva come JPEG
Città #
Chandler 383
Dublin 338
Singapore 204
San Mateo 198
Jacksonville 179
Boardman 140
Hong Kong 117
Altamura 112
Santa Clara 98
Medford 97
Princeton 96
Wilmington 90
Ann Arbor 74
Lawrence 74
Perugia 72
Dong Ket 57
Beijing 41
Andover 39
Helsinki 30
Des Moines 27
Saint Petersburg 26
Ashburn 25
Munich 25
New York 25
Woodbridge 21
Izmir 19
Norwalk 18
Rome 18
Amelia 17
Fremont 17
Los Angeles 17
Falls Church 10
San Paolo di Civitate 10
Brussels 9
Vienna 9
Redwood City 8
Moscow 7
Redmond 7
Renton 6
San Diego 6
Brno 5
Bucu 5
Houston 5
Lausanne 5
Melbourne 5
Simi Valley 5
Auburn Hills 4
Cardiff 4
Olomouc 4
Shanghai 4
Athens 3
Cambridge 3
Corridonia 3
Den Haag 3
Durban 3
Kaohsiung 3
Surrey 3
Tappahannock 3
Auckland 2
Dallas 2
Fairfield 2
Gaborone 2
Hefei 2
Hyderabad 2
Lambeth 2
Lappeenranta 2
Leipzig 2
León 2
Manassas 2
Minya 2
Nanjing 2
Osoppo 2
Perth 2
Plaistow 2
Plymouth 2
Selargius 2
Seoul 2
Spring 2
Swansea 2
Tallinn 2
Terni 2
Abidjan 1
Alexandria 1
Baku 1
Belo Horizonte 1
Central 1
Cepagatti 1
Changsha 1
Chicago 1
College Station 1
Dhaka 1
Edinburgh 1
Falkenstein 1
Frankfurt Am Main 1
Groningen 1
Haifa 1
Hangzhou 1
Hanoi 1
Hanover 1
Henderson 1
Totale 2.901
Salva come PNG Salva come JPEG
Nome #
Liver protein synthesis in physiology and in disease states 93
Hypoglycemia 93
Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans. 91
Alternative indicators of metabolic control 88
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. 84
Effects of dietary protein restriction on fibrinogen and albumin metabolism in nephrotic patients 80
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia. 76
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. 76
A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults 72
Administration of Recombinant Human GH on Alternate Days is sufficient to increase whole Body Protein Synthesis and Lipolysis in GH Deficient Adults 70
Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study. 70
SHORT-TERM TREATMENT WITH LOW DOSES OF RECOMBINANT HUMAN GROWTH HORMONE (GH) STIMULATES LIPOLYSIS IN VISCERAL OBESE MEN 69
18. Insulin required for prandial ghrelin suppression in humans 69
Ethanol impairs post-prandial hepatic protein metabolism 67
Comparison of pharmacokinetics and-dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes mellitus: a double-blind, randomized, cross-over study. 65
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 64
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study. 64
Effects of dietary protein restriction on albumin and fibrinogen synthesis in macroalbuminuric type 2 diabetic patients. 64
Termoablazione laser percutanea quale alternativa all’intervento di tiroidectomia totale nei pazienti ad alto rischio operatorio 62
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. 62
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules 62
Contribution of amino acids and insulin to protein anabolism during meal absorption. 61
Pivotal role of timely basal insulin replacement after metformin failure in sustaining long-term blood glucose control at a target in Type 2 diabetes. 61
A novel surrogate index for hepatic insulin resistance. 58
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes mellitus. 57
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 57
Increased albumin and fibrinogen synthesis in hemodialysis patients with normal nutritional status 56
Advances in Hepatic Encephalopathy and Metabolic Nitrogen Exchange 55
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. 55
Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial 54
Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. 53
Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes. 53
Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes 52
Insulin is required for prandial ghrelin suppression in humans 51
Physical inactivity is the main cause of the metabolic syndrome 50
Chloroquine reduces whole body proteolysis in humans 48
Circulating ghrelin concentrations in the polycystic ovary syndrome 45
Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity: A cross-sectional analysis of the RISC Study 45
Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes 45
Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. 44
L’ipoglicemia silente nella pratica clinica quotidiana: come diagnosticarla, gestirla e prevenirla 44
Low levels of unmodified insulin glargine in plasma of people with type 2 diabetes requiring high doses of basal insulin 43
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 43
PHARMACOKINETIC AND PHARMACODYNAMIC HEAD-TO-HEAD COMPARISON OF CLINICAL, EQUIVALENT DOSES OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC 100 U/ML IN TYPE 1 DIABETES 43
Optimizing the replacement of basal insulin in Type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era. 42
HYPERGLYCEMIA-INDUCED PLATELET ACTIVATION IN TYPE 2 DIABETES MELLITUS IS RESISTANT TO ASPIRIN BUT NOT TO A NITRIC OXIDE-DONATING AGENT. 42
Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis. 41
Effects of dietary protein restriction on fibrinogen and albumin metabolism in nephrotic patients 41
Circulatin ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement 41
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes. 40
Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. 40
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study 40
Ricoveri per ipoglicemia grave in soggetti con diabete mellito di tipo 2: impatto clinico e costi sanitari 40
Dietary protein intake does not affect IgG synthesis in patients with nephrotic syndrome. 39
INSULIN SENSITIVITY IN TYPE 2 DIABETIC PATIENTS IS DIFFERENT BETWEEN GLUCOSE AND PROTEIN METABOLISM 39
Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: The Importance of appropriate resuspension before subcutaneous injection 39
Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement. 38
Effect of sedentary behaviour and vigorous physical activity on segment-specific carotid wall thickness and its progression in a healthy population 37
The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy women 37
Obesity and carotid artery remodeling 37
Nicotinamide counteracts alcohol-induced impairment of hepatic protein metabolism in humans 36
Moderate and large doses of ethanol differentially affect hepatic protein metabolism in humans 36
Body composition and common carotid artery remodeling in a healthy population 36
Insulin sensitivity and beta-cell function in the offspring of type 2 diabetic patients: impact of line of inheritance. 35
Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia 35
Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study. 35
Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk 35
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. 34
Tecniche Nefrologiche e dialitiche 34
One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort 34
Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations 33
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes. 33
Impact of patient and treatment characteristics on glycemic control and hypoglycemia in patients with type 2 diabetes initiated to insulin glargine or NPH: A post hoc, pooled, patient-level analysis of 6 randomized controlled trials 33
Treatment of growth hormone deficiency syndrome in adults 32
Ethanol impairs post-prandial hepatic protein metabolism. 32
Gender differences in basal protein kinetics in young adults 32
How to accurately establish pharmacokinetics/ pharmacodynamics of long- Acting insulins in humans: Relevance to biosimilar insulins 32
Impact of family history on relations between insulin resistance, LDL cholesterol and carotid IMT in healthy adults 31
Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology 31
Ipoglicemia: implicazioni cliniche e impatto sulla salute 31
Effects of whole-body vibration exercise on the endocrine system of healthy men. 30
From Metabolic Normality to Cardiometabolic Risk Factors in Subjects With Obesity 30
Female Sex and Angiotensin-Converting Enzyme (ACE) Insertion/Deletion Polymorphism Amplify the Effects of Adiposity on Blood Pressure 30
Plasma ghrelin concentrations, food intake, and anorexia in liver failure 29
Real-time continuous glucose monitoring decreases the risk of severe hypoglycemia in people with type 1 diabetes and impaired awareness of hypoglycemia 28
Meal intake similarly reduces circulating concentrations of octanoyl and total ghrelin in humans 26
Metabolic effects of an SGLT2 inhibitor (Dapagliflozin) during a period of acute insulin withdrawal and development of ketoacidosis in people with type 1 diabetes. Diabetes care 2020;43:2128– 2136 26
Reductions in A1C with pump therapy in type 2 diabetes are independent of C-peptide and anti-glutamic acid decarboxylase antibody concentrations 23
Plasma Insulin Levels and Hypoglycemia Affect Subcutaneous Interstitial Glucose Concentration 23
Validation of a counseling strategy to promote the adoption and the maintenance of physical activity by Type 2 diabetic subjects. 22
Diurnal Cycling of Insulin Sensitivity in Type 2 Diabetes: Evidence for Deviation From Physiology at an Early Stage 21
GLP-1 RAs as compared to prandial insulin after failure of basal insulin in type 2 diabetes: Lessons from the 4B and Get-Goal DUO 2 trials 21
The physiological basis of insulin therapy in people with diabetes mellitus 20
Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population 19
Glucose Control in Diabetes: Targets and Therapy 19
Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. 18
One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs 16
The role of gastric emptying in glucose homeostasis and defense against hypoglycemia: Innocent bystander or partner in crime? 15
Totale 4.433
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.266
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020221 0 0 0 0 0 40 54 14 51 32 9 21
2020/2021720 5 49 21 47 239 55 53 17 78 24 60 72
2021/2022706 12 137 21 38 18 9 8 231 7 18 99 108
2022/20231.259 99 264 17 89 92 158 0 58 445 1 28 8
2023/2024519 35 49 28 7 2 11 100 0 54 26 103 104
2024/2025487 10 124 31 79 203 40 0 0 0 0 0 0
Totale 4.433